New pill could help shed pounds without needles
NCT ID NCT07243171
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental oral drug called ecnoglutide in 84 Chinese adults who are overweight or obese. The main goal is to check safety and how the body processes the drug, while also measuring weight changes. Participants take either the drug or a placebo daily for several weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ecnoglutide tablets
- What this could lead to
- If successful, this could lead to a new oral medication for weight management, offering a convenient alternative to injections.
- What could go wrong
- This is an early-phase trial with only 84 participants, so results may not apply broadly. Side effects and lack of efficacy are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND/OR OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
China-Japan Friendship Hospital
RECRUITINGBeijing, Beijing Municipality, 100029, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a daily probiotic boost metabolic health and body confidence?
- A new program aims to ease the 'Lost in Transition' struggle for cancer survivors
- Can yoga and breathing curb emotional eating? a new trial investigates
- Can a new pill help manage weight? a First-in-Human trial begins
- Cooking classes and tailored groceries could help teens manage weight
- Could a diabetes drug protect obese Teens' hearts?